Prostate Cancer Clinical Trials in Baltimore

Showing 121-140 of 228 trials

Intraoperative Dosimetry for Prostate Brachytherapy Using Fluoroscopy and Ultrasound

NCT02225925

The purpose of this study is to assess the performance of a system of intraoperative dynamic dosimetry during prostate seed implantation (brachytherapy) including its new elements, to evaluate and refine technical methods of using the system, as well as confirm its performance and accuracy.

Prostate CancerAdenocarcinoma of the Prostate

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins45 participantsStarted Oct 2014

Baltimore, Maryland, United States

COMPLETEDPHASE3< 1 mile

Radiation Therapy in Treating Patients With Stage II Prostate Cancer

NCT00331773

RATIONALE: Giving radiation therapy that uses a 3-dimensional (3-D) image of the tumor to help focus thin beams of radiation directly on the tumor, and giving hypofractionated radiation therapy (higher doses over a shorter period of time), may be less costly with fewer side effects and just as effective in treating prostate cancer. PURPOSE: This randomized phase III trial is studying several different radiation therapy regimens to compare how well they work in treating patients with stage II prostate cancer.

Prostate Cancer

Radiation Therapy Oncology Group1,116 participantsStarted Apr 2006

Phoenix, Arizona, United States • Tucson, Arizona, United States • Auburn, California, United States +293 more locations

Intraoperative Dosimetry for Prostate Brachytherapy Using Fluoroscopy and Ultrasound

Radiation Therapy in Treating Patients With Stage II Prostate Cancer

Prostate Cancer Trials in Other Cities

RE-sensitizing With Supraphysiologic Testosterone to Overcome REsistance (The RESTORE Study)

Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer

Safety Study of MGA271 in Refractory Cancer

Biomarker-Driven Therapy With Nivolumab and Ipilimumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Expressing AR-V7

Music Listening as a Postanesthesia Care Unit (PACU) Nursing Intervention

Phase 1/1b Study to Evaluate the Safety and Tolerability of Ciforadenant Alone and in Combination With Atezolizumab in Advanced Cancers

Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Men With Stage D0 Prostate Cancer

A Multi-centre Study to Assess the Safety, Tolerability, and Pharmacokinetics of Capivasertib (AZD5363) in Combination With Novel Agents in Patients With Metastatic Prostate Cancer

Radiation Therapy in Treating Patients With Prostate Cancer

PROCLAIM: Germline Genetic Testing for Prostate Cancer Patients

Reducing the Effects of Active Surveillance Stress, Uncertainty and Rumination Thru Engagement in Mindfulness Education

Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases

Observational Study of Docetaxel Exposure in Metastatic Prostate Cancer Patients

NY-ESO-1 Plasmid DNA (pPJV7611) Cancer Vaccine

A Study That Provides Long-term Safety Follow-up and Examines Long-term Exposure to Abiraterone Acetate

Stereotactic Ablative Radiotherapy (SABR) for Low Risk Prostate Cancer With Injectable Rectal Spacer

A Study of ZEN003694 in Combination With Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer

OGX-427 in Metastatic Castrate-Resistant Prostate Cancer With Prostate-Specific Antigen Progression While Receiving Abiraterone

Other Conditions in Baltimore